🔴 CalciMedica is trading 6% down today amid biotech-sector weakness

CalciMedica is trading at $2.01, with a -6.07% change amid a broad September 1, 2026 risk-off session and biotech-sector weakness.

• The S&P 500 is down 0.79% and Nasdaq is down 1.10%.
• XBI is down 4.24%, amplifying weakness in this volatile clinical-stage stock.
• The recent 1-for-5 reverse split began split-adjusted trading August 31; no new company-specific negative announcement was identified for September 1.